Penpulimab, an Fc-Engineered IgG1 Anti-PD-1 Antibody, With Improved Efficacy and Low Incidence of Immune-Related Adverse Events

Zhaoliang Huang, Baiyong Li, Tingting Zhong et al.|Frontiers in Immunology|2022

Cited by 42